QYR:  Global Contrast Injector Market Will be 505 M USD in 2022

QYR: Global Contrast Injector Market Will be 505 M USD in 2022

1. According to QYResearch, in the last several years, global market of contrast injector developed rapidly, with an growth rate of 6%. In 2016, global revenue of contrast injector is nearly 402 M USD; the actual production is about 29.5 K units.

2. The classification of contrast injector includes dual-head contrast injector and single-head contrast injector, and the proportion of dual-head contrast injector in 2016 is about 72%, and the proportion is in increasing trend from 2012 to 2016.

Contrast injector is widely used for CT, MRI and angiography. The most proportion of contrast injector is for CT, and the consumption proportion is about 52% in 2016.

3. Europe region is the largest supplier of contrast injector, with a production market share nearly 37% in 2016. North America is the second largest supplier of contrast injector, enjoying production market share nearly 28% in 2016.

4. North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34%.

5. Market competition is intense. Bayer, Bracco, Nemoto, Guerbet, Ulrich medical, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.